Martin ShkreliEvery podcast appearance, updated as new ones drop

Sign up for TBPN’s daily newsletter at TBPN.com (01:22) - SpaceX's Lunar Mass Driver (41:12) - 𝕏 Timeline Reactions (54:37) - AI Coming for Zuck's Job (58:17) - The Great Peptide Debate w/ Martin Shkreli & Max Marchione. Martin Shkreli, often referred to as the "Pharma Bro," is an American investor and former pharmaceutical executive known for his controversial decision to drastically increase the price of the life-saving drug Daraprim. In the conversation, Shkreli expresses skepticism about the growing popularity of peptides, attributing it to psychological factors like identity control and distrust of institutions. He emphasizes the importance of adhering to established pharmaceutical practices and regulatory frameworks to ensure drug safety and efficacy. Max Marchione is the co-founder of Superpower, a health optimization platform focused on proactive, data-driven care and longevity. He works at the intersection of consumer health, diagnostics, and software, building tools that give users deeper visibility into their biology and long-term health. (01:31:35) - Mitchell Green, founder and managing partner of Lead Edge Capital, discusses the firm's recent closure of its $3.5 billion Fund 7, highlighting the strong interest from both existing and new limited partners. He emphasizes Lead Edge's unique approach, leveraging a diverse LP base of world-class executives and entrepreneurs to support portfolio companies through customer introductions, recruiting, and advisory roles. Green also addresses the resilience of the software industry, countering notions of a "SaaS apocalypse" by underscoring the enduring value and stickiness of enterprise software solutions. (01:43:28) - Shane Hegde, co-founder and CEO of Air, a creative operations platform, discusses the company's recent initiatives, including a new ad campaign in The New York Times and their most significant product release to date. He emphasizes that while AI is a powerful tool, it cannot replace the deeply subjective and perfection-driven nature of creative work. Hegde introduces five new features launching tomorrow: access to 50 AI models within Air, a canvas editor for asset manipulation, AI agents for automated edits, a context layer to maintain brand consistency, and a shift to usage-based pricing. (01:52:53) - Dr. Adam Oskowitz, co-founder and Chief Medical Officer of Doctronic, discusses their AI-native care platform that offers free, 24/7 health consultations, connecting users to licensed doctors across all 50 states for $39 per visit. He highlights the platform's efficiency, enabling doctors to see more patients per hour compared to traditional telehealth services, and mentions a pilot program in Utah where their AI system can renew prescriptions without direct physician involvement. Additionally, Dr. Oskowitz notes that the platform's ease of use encourages users to seek care they might otherwise forgo, addressing the longstanding supply-demand mismatch in medicine. (02:00:16) - Robin Vince, CEO of BNY Mellon, discusses the bank's strategic focus on integrating artificial intelligence (AI) to enhance operational efficiency, enrich client services, and expand its service offerings. He highlights the development of Eliza, BNY Mellon's enterprise AI platform, which supports over 125 AI-enabled solutions and empowers employees to build custom AI agents, fostering a culture of innovation. Vince also emphasizes the importance of responsible AI adoption, underscored by BNY Mellon's collaboration with Carnegie Mellon University to advance AI research and education. (02:17:26) - David Senra is the host of the Founders podcast, where he studies and distills the lives of history’s greatest entrepreneurs. Through deep dives into biographies of figures like Steve Jobs, Estée Lauder, and Henry Ford, he focuses on the patterns, habits, and principles behind building e

James Altucher Show: Read the notes at at podcastnotes.org . Don't forget to subscribe for free to our newsletter, the top 10 ideas of the week, every Monday --------- A Note from James: Is he the most hated man in America? I don’t think so. Martin Shkreli was notorious for various reasons that you’ll hear about in this episode—there are some crazy stories—but I’ve come to know Martin over the past few months as both a friend and business partner. Let’s just hear his stories and explanations. I think you’ll agree with me that this is one of the smartest people I’ve ever had on the podcast. Episode Description: Martin Shkreli became one of the most controversial figures in business history—labeled “the most hated man in America,” prosecuted, imprisoned, and publicly vilified. In this conversation, he tells his side of the story. Part 1 focuses on how media narratives form, why conviction and risk-taking matter in entrepreneurship, and the deeper mechanics behind the pharmaceutical controversy that made him famous. He explains the economics of drug pricing, insurance systems, neglected medications, and why public perception diverged so dramatically from what patients actually experienced. The episode also explores learning across disciplines, intellectual courage, prosecutors’ incentives, and how public scandals evolve into legal consequences. Whether you agree with him or not, the discussion raises uncomfortable questions about business, regulation, media, and reputation. What You’ll Learn: Why media narratives can shape public opinion more than facts The real economics behind pharmaceutical pricing and insurance coverage How entrepreneurs learn complex industries without formal training Why conviction and risk tolerance are essential in investing and business How incentives within legal and political systems influence outcomes Timestamped Chapters: [00:02:00] “Most Hated Man in America” — Media Narratives & Reputation [00:03:11] A Note from James [00:03:45] Humor vs. Backlash: Handling Public Criticism [00:06:39] Conviction, Investing & Standing Your Ground [00:09:00] Optimism, Forgiveness & Business Relationships [00:12:08] The Pharma Controversy Begins [00:14:52] From Hedge Funds to Biotech CEO [00:17:40] Learning New Industries from Scratch [00:19:00] Staying Curious & Avoiding Fear of Complexity [00:21:00] Borrowing Knowledge Across Domains [00:23:06] How People Actually Learn Complex Skills [00:29:00] Entrepreneurship, Ego & Motivation [00:31:20] The Daraprim Pricing Decision Explained [00:34:00] Neglected Drugs & Pharma Economics [00:37:00] Profit Motive vs. Public Good [00:41:13] Why He Became the Target [00:45:00] Prosecutors, Incentives & Legal Strategy [00:47:00] Hedge Funds, Technical Violations & Trials [00:50:00] High-Profile Cases & Selective Enforcement [00:53:00] Media Attention & Personal Decisions See Privacy Policy at https://art19.com/privacy and California Privacy Notice at <a href="https://art19.com/privacy#do-not-sell-m

A Note from James: In the last episode, we talked about whether Martin Shkreli really deserves the label “most hated man in America.” My conclusion was no, and I hope you came to the same conclusion after hearing his perspective. In this episode, we shift gears completely. We talk about Bitcoin, crypto, AI, energy, optical computing, and what the future of technology might actually look like. Martin has a very unusual combination of skills—finance, biotech, programming—and I always enjoy hearing how he connects ideas across different fields. That’s what this conversation is about. Episode Description: What happens when AI demand collides with the limits of computing power and energy? In Part 2, Martin Shkreli and James explore the future of technology—from crypto vulnerabilities to optical computing, GPU scaling, and the potential energy crisis driven by artificial intelligence. They discuss whether Bitcoin can survive quantum computing, why stablecoins solve real-world financial problems, and how computing architecture may shift beyond traditional silicon chips. The conversation then moves into AI economics: why companies might spend billions on compute to make better decisions, how energy constraints could shape innovation, and why optical computing could become the next major breakthrough. This episode isn’t about controversy—it’s about technological leverage, incentives, and where computation is heading next. What You’ll Learn: Why quantum computing could eventually threaten Bitcoin’s encryption The real-world advantages of stablecoins and decentralized payments How AI demand could create massive new energy constraints Why optical (photonic) computing may outperform traditional silicon chips How businesses might use large-scale AI compute for strategic decisions Timestamped Chapters: [00:02:00] Bitcoin, Encryption & Quantum Computing Risks [00:03:02] A Note from James [00:03:34] Crypto Markets: Speculation vs. Utility [00:05:23] Banking Control, Debanking & Stablecoins [00:07:40] Moore’s Law, Huang’s Law & The Limits of Silicon [00:08:45] Optical Computing Explained [00:09:12] NVIDIA, Parallelization & Power Consumption [00:10:24] Energy Constraints & The Electrical Grid [00:11:41] AI Energy Demand vs. Countries [00:12:24] Corporate AI Decision-Making at Scale [00:13:37] The Coming Explosion of AI Compute [00:14:20] Energy Efficiency vs. Speed [00:15:17] GPU Efficiency Improvements & Jevons Paradox <stro

A Note from James: Is he the most hated man in America? I don’t think so. Martin Shkreli was notorious for various reasons that you’ll hear about in this episode—there are some crazy stories—but I’ve come to know Martin over the past few months as both a friend and business partner. Let’s just hear his stories and explanations. I think you’ll agree with me that this is one of the smartest people I’ve ever had on the podcast. Episode Description: Martin Shkreli became one of the most controversial figures in business history—labeled “the most hated man in America,” prosecuted, imprisoned, and publicly vilified. In this conversation, he tells his side of the story. Part 1 focuses on how media narratives form, why conviction and risk-taking matter in entrepreneurship, and the deeper mechanics behind the pharmaceutical controversy that made him famous. He explains the economics of drug pricing, insurance systems, neglected medications, and why public perception diverged so dramatically from what patients actually experienced. The episode also explores learning across disciplines, intellectual courage, prosecutors’ incentives, and how public scandals evolve into legal consequences. Whether you agree with him or not, the discussion raises uncomfortable questions about business, regulation, media, and reputation. What You’ll Learn: Why media narratives can shape public opinion more than facts The real economics behind pharmaceutical pricing and insurance coverage How entrepreneurs learn complex industries without formal training Why conviction and risk tolerance are essential in investing and business How incentives within legal and political systems influence outcomes Timestamped Chapters: [00:02:00] “Most Hated Man in America” — Media Narratives & Reputation [00:03:11] A Note from James [00:03:45] Humor vs. Backlash: Handling Public Criticism [00:06:39] Conviction, Investing & Standing Your Ground [00:09:00] Optimism, Forgiveness & Business Relationships [00:12:08] The Pharma Controversy Begins [00:14:52] From Hedge Funds to Biotech CEO [00:17:40] Learning New Industries from Scratch [00:19:00] Staying Curious & Avoiding Fear of Complexity [00:21:00] Borrowing Knowledge Across Domains [00:23:06] How People Actually Learn Complex Skills [00:29:00] Entrepreneurship, Ego & Motivation [00:31:20] The Daraprim Pricing Decision Explained [00:34:00] Neglected Drugs & Pharma Economics <stron

Sign up for TBPN’s daily newsletter at TBPN.com (00:51) - Anthropic Hits $380B Valuation (06:08) - Become Unsloppable (23:27) - 𝕏 Timeline Reactions (45:08) - WSJ Mansion Section (58:20) - Martin Shkreli, an American investor and former pharmaceutical executive, gained notoriety for significantly increasing the price of the drug Daraprim and was later convicted of securities fraud. In the conversation, Shkreli discusses his development of a new product that utilizes his network and AI to estimate venture capital positions in various funding rounds, highlighting significant gains by investors in companies like Anthropic and OpenAI. He also touches on the challenges of accessing accurate investment data and the potential of AI in transforming industries, emphasizing the importance of product development and sales over engineering in business success. (01:34:32) - Connor Hayes, a product leader at Meta, discusses the development and growth of Threads, emphasizing its unique content format and the importance of fostering niche communities. He highlights the "Dear Algo" feature, allowing users to customize their feeds by requesting specific content, and shares insights on integrating AI to assist creators in streamlining content production. Hayes also touches on the challenges of creator monetization, advocating for directing traffic to sustainable revenue sources rather than relying solely on platform payouts. (02:03:30) - Alex Bouzari, CEO and Co-Founder of DDN, discusses his company's role in solving data challenges for AI implementations across enterprises and nations, highlighting collaborations with Nvidia and Elon Musk's ventures. He shares his journey from France to the U.S., emphasizing DDN's evolution from high-performance computing to AI, and underscores the importance of efficient infrastructure in accelerating AI adoption. Bouzari also addresses the competitive landscape, noting the rapid advancements in data center development in China and the Middle East, and stresses the need for the U.S. to enhance its efficiency to remain competitive. (02:29:01) - Brett Adcock, founder and CEO of Figure AI, discusses the company's advancements in humanoid robotics, highlighting the unveiling of their third-generation robot, Figure 03, and the development of a new, highly dexterous hand designed to achieve human-level manipulation capabilities. He emphasizes the importance of creating robots with human-like form and dexterity to seamlessly integrate into environments built for humans, enabling tasks such as folding laundry and handling dishes. Adcock also outlines Figure's strategy to deploy humanoid robots in industrial settings rapidly, with plans to introduce them into homes once they can perform tasks autonomously and reliably over extended periods. (02:55:28) - 𝕏 Timeline Reactions TBPN.com is made possible by: Ramp - https://Ramp.com AppLovin - https://axon.ai Cisco - https://www.cisco.com Cognition - https://cognition.ai Console - https://console.com CrowdStrike - https://crowdstrike.com ElevenLabs - https://elevenlabs.io Figma - https://figma.com Fin - https://fin.ai Gemini - https://gemini.google.com Graphite - https://graphite.com Gusto - https://gusto.com/tbpn Kalshi -

Martin Shkreli is the co-founder of DL Software, the parent company of Godel Terminal , a Bloomberg competitor for financial data. He previously founded the biotech companies Retrophin and Turing Pharmaceuticals and the hedge fund MSMB Capital Management. In this episode of Summation, Martin and Auren discuss: The structural reasons fintech is less competitive than other industries How drug discovery actually works (and doing it from prison) Why AI labs are now out-recruiting hedge funds What Martin learned from being "the most hated man in America" You can find Auren Hoffman on X at @auren and Martin Shkreli on X at @MartinShkreli

THROWBACK EPISODE - Originally streamed August 17, 2022 Martin Shkreli confronts Destiny in heated personal debate after Destiny breaks down Martin's cryptoscam Destiny's Op-Eds and other Articles - https://pragmaticpapers.github.io/ Anything Else Podcast - https://feeds.megaphone.fm/anythingelse YouTube - https://www.youtube.com/destiny Merch - https://store.destiny.gg/ Stream - http://www.kick.com/Destiny Discord - https://discordapp.com/invite/destiny Twitter - /theomniliberal Kick - https://kick.com/Destiny Reddit - r/destiny Instagram - /destiny

(01:19) - Timeline (20:53) - Range Rover Launches New Logo (29:07) - Martin Shkreli. Martin is an American entrepreneur and former pharmaceutical executive known for his work in biotechnology and hedge fund management. He co-founded the hedge funds Elea Capital, MSMB Capital Management, and the biopharmaceutical companies Retrophin and Turing Pharmaceuticals. Shkreli gained national attention during his tenure at Turing, and later faced legal issues related to securities fraud, for which he was convicted in 2017. Despite his controversial public image, he remains a notable figure in the biotech and finance communities. (01:21:40) - Timeline (01:36:11) - Joseph Krause, co-founder and CEO of Radical AI, announced the company's $55 million seed funding round, led by RTX Ventures, marking one of the largest in New York's history. He discussed plans to build an advanced materials R&D facility integrating AI and robotics to accelerate materials science innovation. Krause also shared his background in nanoscience and the journey from academic research to entrepreneurship, emphasizing the importance of culture and lean operations in their growth strategy. (01:45:29) - Timeline (01:53:20) - Joe Weisenthal is an American journalist and financial expert. He serves as the executive editor of news for Bloomberg Digital, co-anchors Bloomberg Television's "What’d You Miss?", and co-hosts the "Odd Lots" podcast. In the conversation, Weisenthal discusses recent positive economic data, including better-than-expected retail sales and jobless claims, and explores the implications of potential Federal Reserve rate cuts on long-term interest rates and mortgage rates. (02:23:53) - Nirav Tolia, co-founder and CEO of Nextdoor, recently discussed the platform's comprehensive redesign aimed at enhancing user engagement and utility. The new Nextdoor introduces three core features: 'News,' integrating content from over 3,500 local publications; 'Alerts,' providing real-time updates on local emergencies; and 'Faves,' an AI-powered tool offering personalized recommendations based on neighborhood conversations. Tolia emphasized that these enhancements are designed to make Nextdoor an indispensable daily resource for neighbors, fostering stronger, safer, and more connected communities. (02:40:13) - Mike Knoop, co-founder of Zapier and host of the ARC Prize, discusses the ARC-AGI benchmark's role in measuring AI's ability to generalize on novel tasks, emphasizing that while AI systems have made progress, they still lag behind human efficiency levels. He highlights the ARC Prize's aim to accelerate AGI development by encouraging open sharing of new ideas and fostering a diverse AI research community. Knoop also introduces ARC V3, an interactive reasoning benchmark designed to challenge emerging AI agent systems, noting its increased complexity and the importance of efficiency constraints to prevent agents from relying on brute-force methods. (03:00:58) - Kyle Samani, co-founder and managing partner at Multicoin Capital, discusses the transformative potential of stablecoins in enabling global access to U.S. dollars, emphasizing that this unprecedented shift is not yet fully appreciated. He highlights the profound implications for global commerce and payments, noting that major consumer software platforms can now legally integrate stablecoins, potentially onboarding billions of users into the crypto ecosystem. Samani also touches on the evolving regulatory landscape, mentioning the passage of the Genius Act and the anticipated Clarity Act, which aim to define regulatory responsibilities and provide clarity for the industry. TBPN.com is made possible by: Ramp - https://ramp.com Figma - https://figma.com Vanta - https://vanta.com Linear - https://linear.app Eight Sleep - https://eightsleep.com/tbpn Wander - https://

In this episode of Gradient Dissent, Lukas Biewald talks with Martin Shkreli — the infamous "pharma bro" turned founder — about his path from hedge fund manager and pharma CEO to convicted felon and now software entrepreneur. Shkreli shares his side of the drug pricing controversy, reflects on his prison experience, and explains how he rebuilt his life and business after being "canceled." They dive deep into AI and drug discovery, where Shkreli delivers a strong critique of mainstream approaches. He also talks about his latest venture in finance software, building Godel Terminal “a Vim for traders", and why he thinks the AI hype cycle is just beginning. It's a wide-ranging and candid conversation with one of the most controversial figures in tech and biotech. Follow Martin Shkreli on Twitter Godel Terminal: https://godelterminal.com/ Follow Weights & Biases on Twitter https://www.linkedin.com/company/wandb Join the Weights & Biases Discord Server: https://discord.gg/CkZKRNnaf3

In this episode of Hims House, Jonathan Stern and Patrick Lester sit down with Martin Shkreli — one of the sharpest and most controversial voices in healthcare. They break down what’s driving Hims’ explosive revenue growth and why the company remains so widely misunderstood. The conversation covers the “Netflix of Healthcare” analogy, GLP-1 compounding and IP risk, and questions around long-term sustainability. Shkreli also breaks down the stock dynamics behind Hims’ unusually high short interest, how hedge funds and quants are positioned, and what the holder list — including Citadel, Farallon, and Renaissance — reveals about how the smartest players on Wall Street are positioned. The episode closes on valuation, scale, and why management execution is likely to be the single most important factor in how the Hims story plays out. 00:00 Introduction 04:00 The Netflix of Healthcare 05:52 Positive Second Derivative Revenue Growth 07:33 Founder-Led Companies 09:13 Comparing Hims to Google 15:30: The Importance of Management 20:15 Hims As Big As UnitedHealthcare? 24:50 GLP-1s and Hims 25:45 Why Big Stock Price Swings are Bullish 27:30 The Rise of Eli Lilly and GLP-1s 34:55 Ozempic Growth and Patent Challenges 36:01 The Complexities of Pharma Patents 44:50 Would Novo Sue Hims? 45:40 Hims, AI, and the Future of Healthcare Platforms 50:30 It's Time for a Healthcare Social Platform 55:19 The Debate on OTC Drugs and Healthcare Access 58:00 Stock Dynamics: Short Interest, Institutional Ownership, Retail Interest 01:06:06 Addressing the Top Bear Arguments 01:08:29 Insider Sales 01:13:24 Top Institutional Holders: Citadel, Farallon, Renaissance, and More 01:25:03 Hims Valuation Disclaimer: This podcast is for informational and entertainment purposes only. Nothing discussed should be considered financial, investment, or legal advice. Always consult with a qualified professional before making financial decisions. Get full access to Hims House at himshouse.substack.com/subscribe

Martin Shkreli, the infamous former pharmaceutical executive, is known for hiking drug prices and his fiery personality. In this intense discussion, he goes full throttle, baiting critics and responding with sharp comebacks. We dive into: 🔹 His controversial drug pricing decisions 🔹 The truth about his securities fraud case 🔹 His lawyer, Benjamin Brafman (who also defended P. Diddy & Michael Jackson) 🔹 The bizarre $5,000 bounty for Hillary Clinton's hair 🔹 Why prosecutors came after him so aggressively Was Shkreli truly a villain, or was he just a scapegoat? Watch and decide! 💬 Drop your thoughts in the comments & don't forget to like and subscribe for more deep dives! 🚀

Martin Shkreli jacked up drug prices, trolled the world, and bought a two million-dollar Wu-Tang album before the age of 35. But the karma (and real) police came for the Pharma Bro when the world caught wind of his price-gouging antics on life saving medicine. From hedge fund schemes to court-room memes, Martin earned the now infamous title of “Most Hated Man in America”. Kyle Prue (How to Piss Off Men) and Miles Bonsignore (Perfect Person, Try Guys) join Misha to give Martin Shkreli a taste of his own medicine. Follow The Big Flop on the Wondery app or wherever you get your podcasts. You can listen to The Big Flop early and ad-free on Wondery+. Join Wondery+ in the Wondery app or on Apple Podcasts. Be the first to know about Wondery’s newest podcasts, curated recommendations, and more! Sign up now at https://wondery.fm/wonderynewsletter Listen to The Big Flop on the Wondery App or wherever you get your podcasts. You can listen early and ad-free on Wondery+. Join Wondery+ in the Wondery App, Apple Podcasts or Spotify. Start your free trial by visiting wondery.com/links/the-big-flop/ now. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info .

Martin Shkreli is America’s most hated pharma bro. In 2015 he bought daraprim which treats HIV and AIDS induced toxoplasmosis and raised the price dramatically. When questioned, he trolled reporters and the public, while actually accommodating a large majority of requests that needed the drug more cheaply. In doing this, he exposed behavior engaged in constantly by big pharma. In this episode, we talk heterodox health, biology and general science. TIMESTAMPS: Intro: 0:00 Shkreli on Being a Troll: 3:04 Turing & A.I.: 4:15 Anti-Aging: 11:00 Trippy Beliefs & Religion: 13:36 A.I.: 15:00 Human Evolution & Health: 20:56 Shkreli's Prison Time: 23:27 Love Life: 24:24 New Startup & Business: 27:04 A.I. & Crypto: 33:05 Who is Satoshi: 36:37 Favorite Books & Prison Time: 37:51 Information Theory: 42:41 Top 5 Rappers: 47:06 Hillary Clinton: 52:03 Martin's Trial: 55:21 Pharma & Medical System: 1:02:56 Was C0VlD Man-Made?: 1:11:56 Relationships & Marriage: 1:22:12 Autism Spectrum: 1:27:59 Being Misunderstood & OnlyFans: 1:32:11 *** AMERICAN ALCHEMY is an original series hosted by Jesse Michels that explores the frontier of science and tech. Each week, we bring you exclusive interviews with some of the leading thinkers of our time. INSTAGRAM ➤ https://www.instagram.com/jessemichels TWITTER ➤ https://twitter.com/AlchemyAmerican EMAIL/BOOKINGS ➤ usa.alchemy@gmail.com SUBSCRIBE TO OUR CHANNEL: https://www.youtube.com/channel/UC7eOJzNRWY4l2UTDvIquxYg?app=desktop original music: https://open.spotify.com/artist/6LlLRudDi60Uy4jcmOSEs1 - martin shkreli pharma bro Elea Capital wu tang clan investing daraprim Learn more about your ad choices. Visit megaphone.fm/adchoices

EPISODE #66: Martin Shkreli is back on the pod to discuss Kamala’s economic policies. We break down all of the details and why they are terrible ideas. The DNC is wrapped up, and we react to the events of the week. The media came after Ben Horowitz and his wife because.. wait for it.. they support Trump. And finally.. the most anticipated event of the week.. PIRATE IDOL. Shkreli is our guest judge this week as 4 contestants compete to earn a regular contributor spot on the Pirate Wires Podcast. Featuring Mike Solana, Brandon Gorrell, Riley Nork, Martin Shkreli Sign Up To Pirate Wires For Free! https://piratewires.co/free_newsletter Topics Discussed: https://www.piratewires.com/p/death-by-vibes Pirate Wires Twitter: https://twitter.com/PirateWires Mike Twitter: https://twitter.com/micsolana Brandon Twitter: https://twitter.com/brandongorrell Riley Twitter: https://x.com/rylzdigital Martin Twitter: https://x.com/MartinShkreli TIMESTAMPS: 0:00 - Welcome Back Martin Shkreli to the pod! 2:00 - Breadlines Are Brat - Breaking Down Kamala’s Economic Policy 16:45 - Price Gauging 26:30 - The Latest Polymarket Report 28:15 - DNC Recap - Including Land Acknowledgements, Vasectomies, and Free Abortions 46:15 - Media Attacks Ben Horowitz and His Wife For Supporting Trump 59:10 - PIRATE IDOL - Who’s Going To Be The Next PW Star?! 1:37:30 - Thanks For Watching! Like & Subscribe #podcast #technology #politics #culture

Martin Shkreli detailed his life story in a new VladTV exclusive. The infamous investor and businessman described growing up in Brooklyn with his parents, who were Albanian immigrants. He talked about his early passion for finance, which led him to join hedge fund Cramer Berkowitz shortly after college. During his young career, Shkreli found success in the pharmaceutical industry and was a millionaire by 28 years old. He also explained his controversial decision to raise prices on various medicines used for various illnesses. Later in the interview, he detailed his $1.5 million purchase of Wu-Tang Clan's one-of-a-kind "Once Upon a Time in Shaolin" album and his public feuds with Ghostface Killah, DJ Akademiks and Lil Wayne. Shkreli opened up about his securities fraud case and serving over four years in prison. To hear what Martin Shkreli has been up to since his release, check out the full interview above.

EPISODE #59: The Mega Pod is here! We’re off next week for the 4th of July, so we figured we’d leave you with some extra content to carry through the break. First up, an instant reaction to the train wreck that was the Presidential debates. We had to wake up early on Friday morning and record a reaction for you guys. Solana & Producer Matt discuss (What up Matt!) Then, back to your regularly scheduled pod episode. Martin Shkreli joins the show to discuss all the betting markets reaction to Trump coin and the downfall of TechCrunch. We are then joined by Kian Sadeghi & Delian Asparouhov to discuss Nucleus Genomicsm, the all-in-one DNA test. Next up, fire alarm enthusiast, Jamaal Bowman, gets voted out in NY and AOC makes a fool of herself at the rally. Finally, Trump promised green cards for all college graduates. Is this a good idea? Makes sense? Hope so. Enjoy! Featuring Mike Solana, Sanjana Friedman, Matt Marlinski, Martin Shkreli, Kian Sadeghi, Delian Asparouhov Sign Up To Pirate Wires For Free! https://piratewires.co/free_newsletter Pirate Wires Twitter: https://twitter.com/PirateWires Mike Twitter: https://twitter.com/micsolana Sanjana Twitter: https://twitter.com/metaversehell Matt Twitter: https://x.com/mattmarlinski Martin Twitter: https://x.com/MartinShkreli Kian Twitter: https://x.com/KianSadeghi5 Delian Twitter: https://x.com/zebulgar TIMESTAMPS: 0:00 - Intro 0:45 - Trump/Biden Debate Friday Morning Instant Reaction 25:00 - Welcome Martin Shkreli To The Pod! 26:00 - The Betting Markets & Trump Coin 41:45 - The Downfall Of Tech Crunch and Tech Media 57:30 - Welcome Kian Sadeghi & Delian Asparouhov to discuss Nucleus Genomicsm 1:28:00 - Shkreli & The Panel Are Back 1:29:40 - The End Of The Squad? Jamaal Bowman, Voted Out, AOC Embarrassing Rally While Being Protested By Yay-Hamas 1:48:00 - Green Cards For All College Graduates? Trump Floats The Idea 2:00:00 - Thanks For Watching Till The End! We’ll Be Back July 12th - Wish Solana A Happy Birthday! #podcast #martinshkreli #trump #biden #technology #politics #culture

LONG — On-chain analytics Dr. Justin Murphy is a renegade social scientist, marriage-arranger, host of the Other Life podcast and newsletter, and founder of IndieThinkers — a membership community for independent intellectuals working on the internet, outside of institutions. In this episode: Why Justin pursued (and then left) academia How to push the limits of the internet intellectual market Favorite obscure genius? Martin Shkreli The economic power of obscure truths Justin's arranged marriage experiments What does Justin think of Ideamarket? Justin’s critique of Ideamarket Bullish on on-chain analytics Why a dignified death > eternal life extension Christianity as a philosophy of life Justin’s next projects What distinguishes IndieThinkers from other communities “Quiet, hard work dominates” Find the ideas that are most explosive EPISODES LINKS: Justin on Twitter Other Life Justin's personal website The Best of Martin Shkreli Arranged Marriages IDEAMARKET LINKS Ideamarket Website I deamarket on Twitter Ideamarket Discord Apple Podcasts